Your browser doesn't support javascript.
loading
Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes.
Kaufmann, Stefan H E.
Affiliation
  • Kaufmann SH; Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany Kaufmann@mpiib-berlin.mpg.de.
mBio ; 8(1)2017 02 28.
Article in En | MEDLINE | ID: mdl-28246359
ABSTRACT
A century ago, Emil von Behring passed away. He was the first to be honored by the Nobel Prize for Medicine in 1901 for the successful therapy of diphtheria and tetanus, which he had developed from the bench to the bed. He also contributed to the foundation of immunology, since his therapy was based on passive immunization with specific antisera. Being an ambitious character, he did not shy away from friction with his colleagues Paul Ehrlich and Elias Metchnikoff and his mentor, Robert Koch. Behring was not only an excellent translational researcher but also a successful entrepreneur and early proponent of public-private partnerships.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetanus / Immunization, Passive / Diphtheria / Immunotherapy Limits: Humans Language: En Journal: MBio Year: 2017 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetanus / Immunization, Passive / Diphtheria / Immunotherapy Limits: Humans Language: En Journal: MBio Year: 2017 Document type: Article Affiliation country: Germany